Amgen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

26,700

Employees26,700

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

26,700

Employees26,700

AMGN Key Statistics

Market cap

141.64B

Market cap141.64B

Price-Earnings ratio

33.72

Price-Earnings ratio33.72

Dividend yield

3.42%

Dividend yield3.42%

Average volume

4.81M

Average volume4.81M

High today

$275.00

High today$275.00

Low today

$262.21

Low today$262.21

Open price

$269.12

Open price$269.12

Volume

13.69M

Volume13.69M

52 Week high

$346.85

52 Week high$346.85

52 Week low

$253.30

52 Week low$253.30

AMGN News

Benzinga 18h

What's Going On With Amgen Stock On Friday?

On Friday, Novo Nordisk A/S NVO released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program. When evaluating the effects of trea...

TipRanks 1d

Novo obesity data positive for Eli Lilly and Amgen, says UBS

UBS analyst Trung Huynh says Novo Nordisk’s (NVO) CagriSema Phase 3 topline obesity data “underwhelmed,” a positive read-through to Eli Lilly (LLY) and Amgen (A...

Analyst ratings

47%

of 34 ratings

Buy

44.1%

Hold

47.1%

Sell

8.8%